In 2014, Congress enacted the Protecting Access to Medicare Act (“PAMA”), changing the landscape of Medicare reimbursement for lab services. PAMA required the Centers for Medicare & Medicaid Services (“CMS”) to establish a single, national Clinical Laboratory Fee Schedule (“CLFS”) based on current charges in the private health care market. Below, we provide background... READ MORE
Reminder: Many Hospitals Will Be Required to Report Lab Price Data as Part of PAMA Changes
Posted on September 3, 2019 in Health Law News
Published by: Hall Render